Medical Device Analytical Testing Outsourcing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Medical Device Analytical Testing Outsourcing Market, By Service Type

7.1.  Medical Device Analytical Testing Outsourcing Market, By Service Type, 2020-2027

7.1.1.    Extractable and leachable

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Material characterization

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    Physical testing

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Bioburden testing

7.1.4.1.        Market Revenue and Forecast (2016-2027)

7.1.5.    Sterility testing

7.1.5.1.        Market Revenue and Forecast (2016-2027)

7.1.6.    Other tests

7.1.6.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Medical Device Analytical Testing Outsourcing Market, By Therapeutic Areas

8.1.  Medical Device Analytical Testing Outsourcing Market, By Therapeutic Areas, 2020-2027

8.1.1.    Cardiology

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Diagnostic Imaging

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Orthopedic

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    IVD

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Ophthalmic

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    General & Plastic Surgery

8.1.6.1.        Market Revenue and Forecast (2016-2027)

8.1.7.    Drug Delivery

8.1.7.1.        Market Revenue and Forecast (2016-2027)

8.1.8.    Endoscopy

8.1.8.1.        Market Revenue and Forecast (2016-2027)

8.1.9.    Dental

8.1.9.1.        Market Revenue and Forecast (2016-2027)

8.1.10.  Diabetes Care

8.1.10.1.      Market Revenue and Forecast (2016-2027)

8.1.11.  Others

8.1.11.1.      Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Medical Device Analytical Testing Outsourcing Market, By Type

9.1.  Medical Device Analytical Testing Outsourcing Market, By Type, 2020-2027

9.1.1.    Reprocessed Devices

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Others

9.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Medical Device Analytical Testing Outsourcing Market, By End-Use Type

10.1.        Medical Device Analytical Testing Outsourcing Market, By End-Use Type, 2020-2027

10.1.1.  Hospital

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Others

10.1.2.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global Medical Device Analytical Testing Outsourcing Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Service Type (2016-2027)

11.1.2.  Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.1.3.  Market Revenue and Forecast, By Type (2016-2027)

11.1.4.  Market Revenue and Forecast, By End-Use Type (2016-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.1.5.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.1.5.3.      Market Revenue and Forecast, By Type (2016-2027)

11.1.5.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.1.6.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.1.6.3.      Market Revenue and Forecast, By Type (2016-2027)

11.1.6.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Service Type (2016-2027)

11.2.2.  Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.2.3.  Market Revenue and Forecast, By Type (2016-2027)

11.2.4.  Market Revenue and Forecast, By End-Use Type (2016-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.2.5.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.2.5.3.      Market Revenue and Forecast, By Type (2016-2027)

11.2.5.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.2.6.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.2.6.3.      Market Revenue and Forecast, By Type (2016-2027)

11.2.6.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.2.7.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.2.7.3.      Market Revenue and Forecast, By Type (2016-2027)

11.2.7.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.2.8.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.2.8.3.      Market Revenue and Forecast, By Type (2016-2027)

11.2.8.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Service Type (2016-2027)

11.3.2.  Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.3.3.  Market Revenue and Forecast, By Type (2016-2027)

11.3.4.  Market Revenue and Forecast, By End-Use Type (2016-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.3.5.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.3.5.3.      Market Revenue and Forecast, By Type (2016-2027)

11.3.5.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.3.6.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.3.6.3.      Market Revenue and Forecast, By Type (2016-2027)

11.3.6.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.3.7.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.3.7.3.      Market Revenue and Forecast, By Type (2016-2027)

11.3.7.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.3.8.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.3.8.3.      Market Revenue and Forecast, By Type (2016-2027)

11.3.8.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Service Type (2016-2027)

11.4.2.  Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.4.3.  Market Revenue and Forecast, By Type (2016-2027)

11.4.4.  Market Revenue and Forecast, By End-Use Type (2016-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.4.5.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.4.5.3.      Market Revenue and Forecast, By Type (2016-2027)

11.4.5.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.4.6.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.4.6.3.      Market Revenue and Forecast, By Type (2016-2027)

11.4.6.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.4.7.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.4.7.3.      Market Revenue and Forecast, By Type (2016-2027)

11.4.7.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.4.8.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.4.8.3.      Market Revenue and Forecast, By Type (2016-2027)

11.4.8.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Service Type (2016-2027)

11.5.2.  Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.5.3.  Market Revenue and Forecast, By Type (2016-2027)

11.5.4.  Market Revenue and Forecast, By End-Use Type (2016-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.5.5.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.5.5.3.      Market Revenue and Forecast, By Type (2016-2027)

11.5.5.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Service Type (2016-2027)

11.5.6.2.      Market Revenue and Forecast, By Therapeutic Areas (2016-2027)

11.5.6.3.      Market Revenue and Forecast, By Type (2016-2027)

11.5.6.4.      Market Revenue and Forecast, By End-Use Type (2016-2027)

Chapter 12.  Company Profiles

12.1.              SGS SA

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Toxikon, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Eurofins Scientific

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Pace Analytical Services, LLC

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Intertek Group plc

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              WuXi AppTec.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              NORTH AMERICAN SCIENCE ASSOCIATES INC.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Envigo

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Charles River Laboratories International Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Medical Device Testing Services

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms